Universal coronavirus vaccine - VaxThera
Latest Information Update: 20 Oct 2023
At a glance
- Originator VaxThera
- Class COVID-19 vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections
Most Recent Events
- 11 Oct 2023 Preclinical trials in COVID-2019 infections (Prevention) in USA (unspecified route) prior to October 2023 (VaxThera pipeline, October 2023)
- 11 Oct 2023 VaxThera pre-IND application fulfilled with the US FDA for COVID-2019 infections prior to October 2023 (VaxThera pipeline, October 2023)